Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasmsMargaret Nieborowska-Skorska, Tomasz Skórski|Blood|2017Cited by 77
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cellsMargaret Nieborowska-Skorska, Tomasz Skórski|Journal of Clinical Investigation|2017Cited by 75